The global external catheters market size was estimated at USD 2.82 billion in 2024 and is projected to reach USD 4.95 billion by 2033, growing at a CAGR of 6.49% from 2025 to 2033. This growth is driven by the rising geriatric population and increasing prevalence of urological disorders such as urinary incontinence and prostate-related conditions.
Moreover, the growing adoption of home healthcare and technological advancements in catheter design and materials are further boosting market demand. The increasing prevalence of urological disorders is a key factor driving growth in the external catheters market. In 2025, OU Health reported that nearly 80 million women in the U.S. experience urinary incontinence (UI), affecting 1 in 2 women. Additionally, data from City of Hope in November 2024 revealed that 11% to 34% of older men experience UI, with 2% to 11% reporting daily occurrences. This substantial burden highlights a growing need for non-invasive urinary management solutions, supporting the continued expansion of the external catheters segment in the coming years.
In addition to the rising burden of urinary incontinence, the increasing prevalence of cancers-such as bladder cancer, prostate cancer, and ovarian cancer-is further contributing to the growing demand for external catheters. Patients undergoing treatment for these cancers often experience urinary complications or require temporary catheterization due to surgery. External catheters, also known as condom catheters, offer a less invasive and more comfortable solution for managing urinary output in such cases, particularly for patients with limited mobility or sensitivity post-treatment. As these cancers continue to rise globally, the need for reliable, non-invasive urinary management options like external catheters is expected to increase, driving sustained market growth.
The increasing preference for external catheters or condom catheters, particularly among female patients, is anticipated to create significant growth opportunities in the market. Several companies in the industry have already reported encouraging feedback, reinforcing the market potential.
Furthermore, the availability of reimbursement for external catheters for both male and female patients is expected to support market adoption significantly. Reimbursement policies reduce the financial burden on patients and healthcare providers, encouraging wider usage and accessibility. This support is particularly crucial in long-term care and chronic condition management settings.
In addition, companies are receiving reimbursement approvals for external catheters. For instance, in April 2023, Ur24 Technology, Inc., a privately held medical device company, achieved a significant milestone by securing Medicare reimbursement approval for its TrueClr external catheter system. Such reimbursement approvals are anticipated to support the market expansion in the coming years.
This product will be delivered within 1-3 business days.
Moreover, the growing adoption of home healthcare and technological advancements in catheter design and materials are further boosting market demand. The increasing prevalence of urological disorders is a key factor driving growth in the external catheters market. In 2025, OU Health reported that nearly 80 million women in the U.S. experience urinary incontinence (UI), affecting 1 in 2 women. Additionally, data from City of Hope in November 2024 revealed that 11% to 34% of older men experience UI, with 2% to 11% reporting daily occurrences. This substantial burden highlights a growing need for non-invasive urinary management solutions, supporting the continued expansion of the external catheters segment in the coming years.
In addition to the rising burden of urinary incontinence, the increasing prevalence of cancers-such as bladder cancer, prostate cancer, and ovarian cancer-is further contributing to the growing demand for external catheters. Patients undergoing treatment for these cancers often experience urinary complications or require temporary catheterization due to surgery. External catheters, also known as condom catheters, offer a less invasive and more comfortable solution for managing urinary output in such cases, particularly for patients with limited mobility or sensitivity post-treatment. As these cancers continue to rise globally, the need for reliable, non-invasive urinary management options like external catheters is expected to increase, driving sustained market growth.
The increasing preference for external catheters or condom catheters, particularly among female patients, is anticipated to create significant growth opportunities in the market. Several companies in the industry have already reported encouraging feedback, reinforcing the market potential.
Furthermore, the availability of reimbursement for external catheters for both male and female patients is expected to support market adoption significantly. Reimbursement policies reduce the financial burden on patients and healthcare providers, encouraging wider usage and accessibility. This support is particularly crucial in long-term care and chronic condition management settings.
In addition, companies are receiving reimbursement approvals for external catheters. For instance, in April 2023, Ur24 Technology, Inc., a privately held medical device company, achieved a significant milestone by securing Medicare reimbursement approval for its TrueClr external catheter system. Such reimbursement approvals are anticipated to support the market expansion in the coming years.
Global External Catheters Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global external catheters market report based on product, material, gender, end use, and region:Product Outlook (Revenue, USD Million, 2021 - 2033)
- Self-Adhesive
- Non-adhesive
Material Outlook (Revenue, USD Million, 2021 - 2033)
- Silicone
- Latex
- Others
Gender Outlook (Revenue, USD Million, 2021 - 2033)
- Male
- Female
End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Home Healthcare
- Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. External Catheters Market Variables, Trends & Scope
Chapter 4. External Catheters Market: Product Estimates & Trend Analysis
Chapter 5. External Catheters Market: Material Estimates & Trend Analysis
Chapter 6. External Catheters Market: Gender Estimates & Trend Analysis
Chapter 7. External Catheters Devices: End Use Estimates & Trend Analysis
Chapter 8. External Catheters Market: Regional Estimates & Trend Analysis
Chapter 9. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Stryker
- BD
- Consure Medical
- Bravida Medical
- TillaCare Ltd
- Coloplast Corp
- Hollister Incorporated
- Ur24Technology, Inc.
- Cardinal Health
- Boehringer Laboratories, LLC
- Medline Industries, LP.
- B. Braun SE
- Ribbel International Limited
- Sterimed Group.
- Apothecaries Sundries Mfg. Pvt. Ltd.
- Medilivescare Manufacturing Pvt. Ltd.
- Hangzhou Rollmed Co., Ltd.
- Ningbo GreatCare Trading Co., Ltd
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 110 |
Published | July 2025 |
Forecast Period | 2024 - 2033 |
Estimated Market Value ( USD | $ 2.82 Billion |
Forecasted Market Value ( USD | $ 4.95 Billion |
Compound Annual Growth Rate | 6.4% |
Regions Covered | Global |
No. of Companies Mentioned | 18 |